Eloxx Pharmaceuticals, Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc. for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23 2018 | ELOX | Eloxx Pharmaceutic ... | Ward Robert | Chief Executive Off ... | Buy | P | 14.34 | 5,000 | 71,700 | 15,000 | 10 K to 15 K (+50.00 %) |
| May 18 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Grant | A | 0.00 | 33,000 | 0 | 137,725 | 104.7 K to 137.7 K (+31.51 %) |
| May 11 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Option Exercise | A | 14.88 | 104,725 | 1,558,308 | 104,725 | |
| May 11 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Grant | A | 0.00 | 104,725 | 0 | 104,725 | 0 to 104.7 K |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Shabtai Gilad | 10% Owner | Buy | P | 9.75 | 75,000 | 731,250 | 3,351,770 | 3.3 M to 3.4 M (+2.29 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 9.75 | 93,333 | 909,997 | 520,396 | 427.1 K to 520.4 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 9.75 | 172,626 | 1,683,104 | 962,504 | 789.9 K to 962.5 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 9.75 | 84,041 | 819,400 | 468,585 | 384.5 K to 468.6 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 9.75 | 93,333 | 909,997 | 520,396 | 427.1 K to 520.4 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 9.75 | 172,626 | 1,683,104 | 962,504 | 789.9 K to 962.5 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 9.75 | 84,041 | 819,400 | 468,585 | 384.5 K to 468.6 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kleijwegt Martijn | Director | Buy | P | 9.75 | 300,000 | 2,925,000 | 2,953,673 | 2.7 M to 3 M (+11.31 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 93,333 | 909,997 | 520,396 | 427.1 K to 520.4 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 172,626 | 1,683,104 | 962,504 | 789.9 K to 962.5 K (+21.85 %) |
| May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 84,041 | 819,400 | 468,585 | 384.5 K to 468.6 K (+21.85 %) |